Literature DB >> 2589102

A fatal toxicity index for antidepressant poisoning.

J A Henry1.   

Abstract

Since depressed patients are liable to attempt suicide by self-poisoning, fatal poisoning from overdose is an important part of the overall assessment of any antidepressant drug. Because prescription figures for drugs are available in Britain, a Fatal Toxicity Index can be calculated in terms of deaths (from national mortality data) per million National Health Service prescriptions. This was carried out for the years 1975-1984 (Cassidy and Henry 1987), and has since been updated. The older tricyclic antidepressants as a group had a higher Fatal Toxicity Index than the mean for this drugs studied. Monoamine oxidase inhibitors had intermediate toxicity, and newer drugs introduced since 1973 had lower toxicity than the mean figure for all drugs, which was 34.9 deaths per million prescriptions. If drugs are equally effective clinically, serious consideration should be given to prescribing antidepressants with a lower fatal toxicity as a contribution to suicide prevention.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589102     DOI: 10.1111/j.1600-0447.1989.tb03045.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  11 in total

Review 1.  The safety of antidepressants.

Authors:  F de Jonghe; J A Swinkels
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 2.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

3.  Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose.

Authors:  Keith Hawton; Helen Bergen; Sue Simkin; Jayne Cooper; Keith Waters; David Gunnell; Navneet Kapur
Journal:  Br J Psychiatry       Date:  2010-05       Impact factor: 9.319

Review 4.  Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-01       Impact factor: 5.270

5.  Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide.

Authors:  N Freemantle; A House; F Song; J M Mason; T A Sheldon
Journal:  BMJ       Date:  1994-07-23

Review 6.  Psychotropic drugs, aging and community care.

Authors:  M Philpot; A Puranik
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

7.  Antidepressants in suicide: differences in fatality and drug utilisation.

Authors:  J Malmvik; C G Löwenhielm; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 8.  Antidepressant toxicity and the need for identification and concentration monitoring in overdose.

Authors:  B M Power; L P Hackett; L J Dusci; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 9.  Antidepressant drugs and the emergence of suicidal tendencies.

Authors:  M H Teicher; C A Glod; J O Cole
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

10.  A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdose.

Authors:  David Taylor; Alan Lenox-Smith; Andrew Bradley
Journal:  Ther Adv Psychopharmacol       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.